-
Journal - March 2025
- 46 Pages
Global
From €403EUR$425USD£340GBP
- Report
- September 2024
- 116 Pages
Mexico
From €2675EUR$3,024USD£2,337GBP
- Book
- October 2019
- 153 Pages
- Report
- December 2024
- 321 Pages
Global
From €2516EUR$2,655USD£2,123GBP
- Report
- August 2024
- 320 Pages
Global
From €2516EUR$2,655USD£2,123GBP
- Report
- July 2024
- 280 Pages
Global
From €2516EUR$2,655USD£2,123GBP
- Report
- January 2024
- 219 Pages
Global
From €3383EUR$3,570USD£2,855GBP
- Report
- December 2023
- 290 Pages
Global
From €3383EUR$3,570USD£2,855GBP
- Report
- October 2023
- 360 Pages
Global
From €3497EUR$3,690USD£2,951GBP
- Report
- June 2023
- 266 Pages
Global
From €3383EUR$3,570USD£2,855GBP
- Report
- April 2023
- 250 Pages
Global
From €3383EUR$3,570USD£2,855GBP
- Report
- January 2023
- 221 Pages
Global
From €3383EUR$3,570USD£2,855GBP
- Report
- June 2022
- 269 Pages
Global
From €3275EUR$3,456USD£2,764GBP
- Report
- May 2022
- 225 Pages
Global
From €3275EUR$3,456USD£2,764GBP
- Report
- July 2021
- 277 Pages
Global
From €3517EUR$3,712USD£2,969GBP
- Book
- November 2024
- 464 Pages

Biomedicine is a branch of biotechnology that focuses on the development of medical treatments and products. It involves the use of living organisms, such as bacteria, viruses, and cells, to create treatments and products that can be used to diagnose, prevent, and treat diseases. Biomedicine also includes the development of medical devices, such as prosthetics, and the use of genetic engineering to create new treatments.
Biomedicine is a rapidly growing field, with many companies investing in research and development. Companies in the biomedicine market are focused on developing treatments and products for a variety of diseases, including cancer, diabetes, and cardiovascular diseases. They are also working to develop treatments for rare diseases and to improve existing treatments.
Some of the companies in the biomedicine market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Celgene, Gilead Sciences, Johnson & Johnson, Merck, Novartis, Pfizer, and Roche. Show Less Read more